News | February 09, 2024
Spriya Lifescience Q3 FY24 PAT jumps 213% at Rs. 29.79 Cr
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
The new campus has been designed as an employee-centred experience and ecosystem zone
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Medway setup a state-of-the-art Heart Institute in Chennai
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Subscribe To Our Newsletter & Stay Updated
